secwatch / observer
8-K filed May 5, 2026, 7:59 PM ET ticker AVNS CIK 0001606498
earnings confidence low sentiment neutral materiality 0.25

Avanos Medical announces Q1 2026 results; filing includes no financial figures

AVANOS MEDICAL, INC.

2026-Q1 EPS reported $0.11 revenue$182,200,000
item 2.02item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001606498-26-000061
form_type
8-K
ticker
AVNS
cik
0001606498
company_name
AVANOS MEDICAL, INC.
filed_at
2026-05-05T23:59:59+00:00
discovered_at
2026-05-14T18:02:32.584401+00:00
generated_at
2026-05-14T23:23:27.567249+00:00
sec_items
["2.02", "9.01"]
event_type
earnings
sentiment
neutral
materiality_score
0.25
calibrated_materiality_score
0.25
confidence
low
secwatch_canonical_url
https://secwatch.observer/filing/0001606498-26-000061
json_url
https://secwatch.observer/filing/0001606498-26-000061.json
markdown_url
https://secwatch.observer/filing/0001606498-26-000061.md
text_url
https://secwatch.observer/filing/0001606498-26-000061.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/0001606498-26-000061-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/avns-20260505.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

295be4d8ae70b30b8c86ba7c744a7b161585d13f

AVANOS MEDICAL, INC. reported financial results for the three months ended March 31, 2026.

On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.

SEC 8-K Item 2.02 confidence 0.9 SEC evidence

Comparable filings

IREN

IREN holds Q3 FY26 earnings call; transcript lacks financial specifics in filing

IREN Ltd May 11, 2026, 7:59 PM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.

Comparable filing

On May 7, 2026, IREN Limited (the “Company”) conducted a conference call to discuss its financial results for the three months ended March 31, 2026.

Filing page SEC filing

WHLR

Wheeler REIT announces Q1 2026 results available on investor website; no specific figures provided in 8-K

Wheeler Real Estate Investment Trust, Inc. May 8, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.

Comparable filing

On May 8, 2026, Wheeler Real Estate Investment Trust, Inc. (the “Company”) issued a press release announcing that it had reported its financial and operating results for the three months ended March 31, 2026.

Filing page SEC filing

Golub Capital Direct Lending Unlevered Corp

Golub Capital Direct Lending Unlevered Q2 2026 earnings presentation filed; no financial figures in 8-K text

Golub Capital Direct Lending Unlevered Corp May 8, 2026, 7:59 PM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.

Comparable filing

On May 8, 2026 , in connection with the release of its financial results for its second fiscal quarter ended March 31, 2026

Filing page SEC filing

GME

GameStop Q1 record net income $389.6M, revenue up 14%, new $2B buyback

GameStop Corp. June 2, 2026, 4:43 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings

This filing

On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.

Comparable filing

Net sales were $835.3 million for the first quarter

Filing page SEC filing

GTLB

GitLab Q1 revenue $264M (+23% YoY); plans 14% workforce cut, $30-35M charges

Gitlab Inc. June 2, 2026, 4:17 PM ET earnings Items 2.02, 2.05, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings

This filing

On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.

Comparable filing

in such filing. --- EX-99.1 (EX-99.1) --- GitLab Reports First Quarter Fiscal Year 2027 Financial Results First Quarter Fiscal Year 2027 Highlights: • Total revenue of $264.2 million, up 23% year-over-year • GAAP operating margin of (6)%; non-GAAP operating margin of 14% • Operating cash flow of $149.2 million and non-GAAP adjusted free cash flow of $146.7

Filing page SEC filing

PETS

PetMed Q4 sales fall 15.6% to $42.8M; FY net loss widens to $57.3M on goodwill impairment

PETMED EXPRESS INC June 2, 2026, 4:15 PM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings

This filing

On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.

Comparable filing

Net sales of $179.0 million compared to $227.0 million in the prior year, a decrease of 21.1%, primarily driven by a decline in prescription medication sales. • Net loss of $57.3 million, or $(2.74) per diluted share, compared to a net loss of $6.3 million, or $(0.30) per diluted share in the prior year.

Filing page SEC filing

SPWH

Sportsman's Warehouse Q1 net sales up 2.8% to $256.1M; same-store sales +2.1%; net loss $21.8M

SPORTSMAN'S WAREHOUSE HOLDINGS, INC. June 2, 2026, 4:10 PM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings

This filing

On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.

Comparable filing

and generating positive free cash flow to further strengthen our balance sheet through debt reduction.” For the thirteen weeks ended May 2, 2026: • Net sales increased 2.8% to $256.1 million, compared to $249.1 million in the first quarter of fiscal year 2025. Performance was driven primarily by a 7.4% gain in Hunting and Shooting Sports, led by firearms, ammunition,

Filing page SEC filing

PANW

Palo Alto Networks Q3 revenue $3.0B (+31% YoY); NGS ARR $8.1B (+60% YoY)

Palo Alto Networks Inc June 2, 2026, 4:08 PM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings

This filing

On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.

Comparable filing

chief financial officer of Palo Alto Networks. Third Quarter Fiscal 2026 Financial Highlights • Total revenue for the fiscal third quarter 2026 grew 31% year over year to $3.0 billion. This includes $388 million from CyberArk and Chronosphere. • Next-Generation Security ARR for the fiscal third quarter 2026 grew 60% year over year to $8.1 billion. This

Filing page SEC filing

Source: SEC EDGAR
accession 0001606498-26-000061
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.